Others titles

  • New ATC Code 2018
  • New ATC Update and Alterations
  • New DDD Updates and Alterations


  • ATC Classification
  • ATC Alterations
  • DDD Alterations
  • New ATC
  • New DDD

Anatomical Therapeutic Chemical Alterations 2005 to 2018

This dataset contains the ATC (Anatomical Therapeutic Chemical) Alterations from 2005 to 2018.

Log in to download

Get The Data

For getting access to data download links please read and accept the end-user license agreement.
Your Data License
  • Research
    Non-Commercial, Share-Alike, Attribution Free Forever
  • Commercial
    Commercial Use, Remix & Adapt, White Label Log in to download


Cumulative overview of all ATC (Anatomical Therapeutic Chemical) alterations performed in the period 2005 to 2018. The year changed is when the alterations were implemented in the ATC/DDD (Anatomical Therapeutic Chemical/Defined Daily Dose) Index. Active ingredients which fulfill one of the following criteria will normally be included in the ATC system. They are existing well defined chemical entities used in a variety of countries. In ATC the active substances are divided into different groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

Drugs are classified in groups at five different levels. The drugs are divided into fourteen main groups (1st level), with pharmacological/therapeutic subgroups (2nd level). The 3rd and 4th levels are chemical/pharmacological/therapeutic subgroups and the 5th level is the chemical substance. The 2nd, 3rd and 4th levels are often used to identify pharmacological subgroups when that is considered more appropriate than therapeutic or chemical subgroups.

About this Dataset

Data Info

Date Created


Last Modified




Update Frequency


Temporal Coverage


Spatial Coverage

United States


John Snow Labs; WHO Collaborating Centre for Drug Statistics Methodology;

Source License URL

Source License Requirements


Source Citation



ATC Classification, ATC/DDD, ATC Alterations, DDD Alterations, New ATC, New DDD

Other Titles

New ATC Code 2018, New ATC Update and Alterations, New DDD Updates and Alterations

Data Fields

Name Description Type Constraints
Previous_ATC_CodePrevious ATC Codestring-
Substance_NameSubstances Indicated for Rare Disorders with Individual Dosingstring-
New_ATC_CodeNew or altered ATC (Anatomical Therapeutic Chemical) Codestring-
Year_ChangedYear when ATC Code was altereddate-
Other_ATC_CodeOther Anatomical Therapeutic Chemical Codestring-
Previous_ATC_Level_NamePrevious Name of ATC Level Anatomical Therapeutic Chemicalstring-
New_ATC_Level_Name_or_New_ATC_LevelNew or altered ATC (Anatomical Therapeutic Chemical) Namestring-

Data Preview

Previous ATC CodeSubstance NameNew ATC CodeYear ChangedOther ATC CodePrevious ATC Level NameNew ATC Level Name or New ATC Level
A03AE02tegaserodA06AX062013A05AABile acid preparationsBile acids and derivatives
A03AE04prucaloprideA06AX052013B02BD08eptacog alfacoagulation factor VIIa
A10BX04exenatideA10BJ012017J01CR01ampicillin and enzyme inhibitorampicillin and beta-lactamase inhibitor
A10BX07liraglutideA10BJ022017J01CR02amoxicillin and enzyme inhibitoramoxicillin and beta-lactamase inhibitor
A10BX09dapagliflozinA10BK012017J01CR03ticarcillin and enzyme inhibitorticarcillin and beta-lactamase inhibitor
A10BX10lixisenatideA10BJ032017J01CR05piperacillin and enzyme inhibitorpiperacillin and beta-lactamase inhibitor
A10BX11canagliflozinA10BK022017J01DD51cefotaxime, combinationscefotaxime and beta-lactamase inhibitor
A10BX12empagliflozinA10BK032017J01DD52ceftazidime, combinationsceftazidime and beta-lactamase inhibitor
A10BX13albiglutideA10BJ042017J01DD62cefoperazone, combinationscefoperazone and beta-lactamase inhibitor
A10BX14dulaglutideA10BJ052017J01DH51imipenem and enzyme inhibitorimipenem and cilastatin